Background: Age-related macular degeneration (AMD) is a multifactorial retinal disease in which alterations in lipid metabolism and dysregulation of the complement system play a central role. The aim of this study was to characterize a novel double-knockout (DK) mouse model deficient in apolipoprotein E and complement factor H (ApoE−/–Cfh−/−) as an experimental model of early and intermediate AMD.
Methods: ApoE−/–Cfh−/− mice and wild-type controls underwent comprehensive morphological, ultrastructural, biochemical, and molecular analyses. Retinal and retinal pigment epithelium (RPE) integrity, Bruch's membrane (BM) morphology, lipid accumulation, complement activation, angiogenic signaling, and synaptic organization were evaluated using histology, electron microscopy, immunohistochemistry, biochemical assays, and gene expression analyses.
Results: DK mice exhibited significant RPE thinning, disruption of tight junctions, vacuolization, and BM thickening (p < 0.05). Lipid accumulation and plasma lipid levels significantly increased compared with controls (p < 0.01). Complement activation was significantly enhanced, as evidenced by increased C5b-9 deposition (p < 0.01). In addition, DK mice exhibited increased vascular endothelial growth factor expression (p < 0.05), altered matrix metalloproteinase activity (p < 0.05), and significant synaptic disorganization between photoreceptors and second-order neurons (p < 0.05).
Conclusions: The ApoE−/–Cfh−/− mouse reproduces key molecular and structural features of early and intermediate retinal degeneration with statistically significant alterations. Although it does not progress to advanced disease stages, it represents a valuable model to investigate several factors of AMD pathogenesis and evaluate therapeutic strategies targeting early disease mechanisms.
| [1] |
Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2): e106-e116.
|
| [2] |
Maurya M, Bora K, Blomfield A, et al. Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration. Neural Regen Res. 2023; 18(10): 2173-2181.
|
| [3] |
Spaide RF, Jaffe GJ, Sarraf D, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data. Ophthalmology. 2020; 127(5): 616-636.
|
| [4] |
Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006; 58(3): 353-363.
|
| [5] |
Curcio CA. Antecedents of soft drusen, the specific deposits of age-related macular degeneration, in the biology of human macula. Invest Ophthalmol Vis Sci. 2018; 59(4):AMD182.
|
| [6] |
Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch Arztebl Int. 2020; 117: 513-520.
|
| [7] |
Wong TY, Hyman L. Population-based studies in ophthalmology. Am J Ophthalmol. 2008; 146(5): 656-663.
|
| [8] |
Apte RS. Age-related macular degeneration. N Engl J Med. 2021; 385(6): 539-547.
|
| [9] |
Fleckenstein M, Keenan TDL, Guymer RH, et al. Age-related macular degeneration. Nat Rev Dis Prim. 2021; 7(1):31.
|
| [10] |
Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol. 2002; 13(3): 171-175.
|
| [11] |
Velilla S, García-Medina JJ, García-Layana A, et al. Smoking and age-related macular degeneration: review and update. J Ophthalmol. 2013; 2013: 1-11.
|
| [12] |
Toomey CB, Johnson LV, Bowes Rickman C. Complement factor H in AMD: bridging genetic associations and pathobiology. Prog Retin Eye Res. 2018; 62: 38-57.
|
| [13] |
Shang P, Ambrosino H, Hoang J, et al. The complement factor H (Y402H) risk polymorphism for age-related macular degeneration affects metabolism and response to oxidative stress in the retinal pigment epithelium. Free Radic Biol Med. 2024; 225: 833-845.
|
| [14] |
Coffey PJ, Gias C, McDermott CJ, et al. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci USA. 2007; 104(42): 16651-16656.
|
| [15] |
Davignon J, Bouthillier D, Nestruck AC, Sing CF. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc. 1988; 99: 100-110.
|
| [16] |
Wiegman A, Sijbrands EJG, Rodenburg J, et al. The apolipoprotein Ε4 allele confers additional risk in children with familial hypercholesterolemia. Pediatr Res. 2003; 53(6): 1008-1012.
|
| [17] |
Klaver CCW, Kliffen M, Van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998; 63(1): 200-206.
|
| [18] |
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, et al. Animal models of cardiovascular diseases. Biomed Res Int. 2011; 2011(1):497841.
|
| [19] |
Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001; 104(4): 448-454.
|
| [20] |
Purroy A, Roncal C, Orbe J, et al. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification. Atherosclerosis. 2018; 278: 124-134.
|
| [21] |
McGraw AP, Bagley J, Chen W, et al. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. JAHA. 2013; 2(1):e000018.
|
| [22] |
Vanherle S, Janssen A, Gutiérrez De Ravé M, et al. APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model. Mol Psychiatry. 2025; 30(10): 4512-4528.
|
| [23] |
Dong G, Liu Y, Liu H, Qiao C, Chen X, Wang L. Effect of hyperbaric oxygen treatment on lipid metabolism and neurovascular microenvironment in an apolipoprotein E knockout mouse model. J Integr Neurosci. 2025; 24(7):39656.
|
| [24] |
Alagarsamy J, Jaeschke A, Hui DY. Apolipoprotein E in cardiometabolic and neurological health and diseases. Int J Mol Sci. 2022; 23(17):9892.
|
| [25] |
Rakoczy PE, Zhang D, Robertson T, et al. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol. 2002; 161(4): 1515-1524.
|
| [26] |
Elizabeth Rakoczy P, Yu MJT, Nusinowitz S, Chang B, Heckenlively JR. Mouse models of age-related macular degeneration. Exp Eye Res. 2006; 82(5): 741-752.
|
| [27] |
Ahsan B, Aldwaikat A, Aboud O, Ramadan A, Abu-Asab MS. Retinal and choroidal capillaries contribution to age-related macular degeneration (AMD) phenotypes in murine models of the disease. Ultrastruct Pathol. 2020; 44(2): 174-181.
|
| [28] |
Ramkumar HL, Zhang J, Chan C-C. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res. 2010; 29(3): 169-190.
|
| [29] |
Fernández-Robredo P, Recalde S, Arnáiz G, et al. Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-E deficient mice. Curr Eye Res. 2009; 34(7): 543-552.
|
| [30] |
Hernandez M, Recalde S, Garcia-Garcia L, et al. Preclinical evaluation of a cell-based gene therapy using the sleeping beauty transposon system in choroidal neovascularization. Mol Ther Meth Clin Dev. 2019; 15: 403-417.
|
| [31] |
Cuenca N, Pinilla I, Fernández-Sánchez L, et al. Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice. Exp Eye Res. 2010; 91(2): 273-285.
|
| [32] |
Linsel-Nitschke P, Jehle AW, Shan J, et al. Potential role of ABCA7 in cellular lipid efflux to apoA-I. J Lipid Res. 2005; 46(1): 86-92.
|
| [33] |
Ivanescu A, Fernández-Robredo P, Heras-Mulero H, et al. Modifying choroidal neovascularization development with a nutritional supplement in mice. Nutrients. 2015; 7(7): 5423-5442.
|
| [34] |
Zarranz-Ventura J, Fernández-Robredo P, Recalde S, et al. Transforming growth factor-Beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides. PLoS One. 2013; 8(5):e65434.
|
| [35] |
Williams JAE, Greenwood J, Moss SE. Retinal changes precede visual dysfunction in the complement factor H knockout mouse. PLoS One. 2013; 8:e68616.
|
| [36] |
Abhyankar SD, Luo Q, Hartman GD, et al. High-fat Western diet induces retinal and metabolic alterations in APOE3 and APOE4 knock-in mice. Sci Rep. 2026; 8:4873.
|
| [37] |
Malek G, Johnson LV, Mace BE, et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA. 2005; 10: 11900-11905.
|
| [38] |
Booij JC, Baas DC, Beisekeeva J, Gorgels TGMF, Bergen AAB. The dynamic nature of Bruch's membrane. Prog Retin Eye Res. 2010; 29(1): 1-18.
|
| [39] |
Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017; 60: 201-218.
|
| [40] |
Fragiotta S, Sacconi R, Beretta F, Querques G. Basal laminar deposits and pseudodrusen: rethinking their role in age-related macular degeneration progression. Retina. 2026; 46: 399-409.
|
| [41] |
Rudolf M, Mir Mohi Sefat A, Miura Y, et al. ApoA-I mimetic peptide 4F reduces age-related lipid deposition in murine Bruch's membrane and causes its structural remodeling. Curr Eye Res. 2018; 43(1): 135-146.
|
| [42] |
Dithmar S, Curcio CA, Le NA, Brown S, Grossniklaus HE. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci. 2000; 41(8): 2035-2042.
|
| [43] |
Kaarniranta K, Uusitalo H, Blasiak J, et al. Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res. 2020; 79:100858.
|
| [44] |
Curcio CA, Johnson M, Rudolf M, Huang J-D. The oil spill in ageing bruch membrane. Br J Ophthalmol. 2011; 95(12): 1638-1645.
|
| [45] |
Cao X, Guo Y, Wang Y, et al. Effects of high-fat diet and Apoe deficiency on retinal structure and function in mice. Sci Rep. 2020; 10(1):18601.
|
| [46] |
Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005; 102(20): 7227-7232.
|
| [47] |
Clark SJ, Bishop PN. The eye as a complement dysregulation hotspot. Semin Immunopathol. 2018; 40(1): 65-74.
|
| [48] |
Pickering MC, Cook HT, Warren J, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet. 2002; 31(4): 424-428.
|
| [49] |
Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016; 15(6): 385-403.
|
| [50] |
Tarallo V, Hirano Y, Gelfand BD, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell. 2012; 149(4): 847-859.
|
| [51] |
Shelley EJ, Madigan MC, Natoli R, Penfold PL, Provis JM. Cone degeneration in aging and age-related macular degeneration. Arch Ophthalmol. 2009; 127(4): 483-492.
|
| [52] |
Hu TH, Huang CC, Wu CL, et al. Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma. Mod Pathol. 2005; 18(5): 663-672.
|
| [53] |
Lundh Von Leithner P, Kam JH, Bainbridge J, et al. Complement factor H is critical in the maintenance of retinal perfusion. Am J Pathol. 2009; 175(1): 412-421.
|
Rights & permissions
2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.
PDF
(6830KB)
